Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 10 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "Cosmo and Glenmark Announce UK MHRA Approval of Winlevi? for Treatment of Acne".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases